Paris (ots/PRNewswire) - - GenOdyssee Has Received Notice of Allowance of European Patent Application Covering Its Core Natural Evolution Technology Invented in 2002, and Received Broad Product Applications Protection Rights to All Cytokine Families GenOdyssee (GO), a biotechnology company dedicated to ...
Paris (ots/PRNewswire) - - GenOdyssee has Received Notice of Allowance of United States Patent Application Covering it's Lead HCV Interferon-Alpha Product GEA007.1, a Natural Protein With Improved Anti-HCV Genotype 1 Activity GenOdyssee S.A., a biotechnology company dedicated to the discovery and ...
Paris (ots/PRNewswire) - GenOdyssee S.A., a biotechnology company dedicated to the discovery of novel protein therapeutic products, has entered into a research and development cooperation agreement with Baxter AG. GenOdyssee will use its unique intellectual property position in the field of protein therapeutics, as well as its proprietary technology and integrated processes, in the discovery of novel blood clotting ...